Press Releases

 

           

DayStar Announces Proposed Public Offering of Common Stock

 

HALFMOON, N.Y., Oct. 2 /PRNewswire-FirstCall/ -- DayStar Technologies, Inc. (Nasdaq: DSTI) announced today the filing with the Securities and Exchange Commission of an amended registration statement on Form SB-2 pursuant to which the company intends to offer 15,000,000 shares of common stock. In connection with the offering, DayStar will grant the underwriters an option to purchase up to an additional 2,250,000 shares of common stock to cover any over-allotments. 

 

DayStar plans to use the net proceeds from the offering for the repayment in full of $9.2 million of existing indebtedness for borrowed funds and to engineer to-scale and manufacture the company's proprietary deposition tool. The company intends to use the remaining net proceeds from the offering for the construction of a 25MW manufacturing line, working capital and other general corporate purposes.

 

ThinkEquity Partners LLC will serve as the sole bookrunning lead manager for the proposed offering.

 

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. The registration statement on Form SB-2 is available on the Securities and Exchange Commission's website at http://www.sec.gov. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

When they become available, copies of the prospectus for the offering may be obtained from ThinkEquity Partners LLC, 600 Montgomery Street, 8th Floor, San Francisco, CA 94111 or prospectus@thinkequity.com.

 

About DayStar Technologies, Inc.

 

DayStar Technologies, Inc. is engaged in the development, manufacturing, and marketing of photovoltaic products based upon CIGS thin film semiconductor technology.

 

This release contains certain forward-looking statements of expected future developments, as defined in the Private Securities Litigation Reform Act of 1995. The forward-looking statements in this release include the intention of the company to offer and sell shares of common stock. These forward-looking statements involve risks and uncertainties that could cause the actual results to differ materially from those anticipated by these forward-looking statements. Actual events or results may differ materially as a result of many factors, including but not limited to the risk that the underwriters decide to not proceed with or consummate the proposed offering due to general economic conditions, stock market conditions or otherwise.

 

About InfusionCapital:

 

InfusionCapital (www.infusioncapital.com), an investment banking consultancy firm located in Celebration, Florida, specializes in a unique, integrated approach to corporate governance and capital formation.  The firm has extensive experience in assisting client companies with each phase of capitalization and the complex processes that accompany it. 

 

For more information, contact:

Kellie Caughorn

InfusionCapital

407-566-1051

kcaughorn@InfusionCapital.com

www.infusioncapital.com  

 

 

 

© 2007 InfusionCapital. All Rights Reserved